ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】Cash flow
Market cap
¥608.6B
P/E ratio
18.2x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 6,059 | 6,044 | 5,552 | 5,593 | 6,159 | 6,058 | 6,376 | 7,216 | 7,418 | 8,251 | 11,620 |
| Cash from operations | 11,292 | 11,324 | 13,428 | 19,154 | 21,745 | 19,040 | 20,008 | 27,250 | 30,924 | 34,245 | 36,917 |
| Capital expenditures | -3,964 | -4,563 | -3,777 | -5,000 | -6,416 | -5,586 | -8,721 | -10,267 | -8,473 | -7,979 | -9,080 |
| Cash from investing | -9,024 | -6,066 | -9,511 | -11,014 | -10,245 | -9,405 | -10,237 | -16,406 | -13,176 | -16,317 | -89,170 |
| Payments for dividends | -2,050 | -2,278 | -2,278 | -2,506 | -2,506 | -3,078 | -2,965 | -3,422 | -4,676 | -5,475 | -7,072 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | - | -5,000 |
| Proceeds from issuance of term debt, net | 102 | 661 | 1,123 | 591 | 101 | 5,032 | 2,883 | 9,450 | 220 | 1,605 | 14,908 |
| Repayments of term debt | -1,280 | -1,190 | -678 | -333 | -646 | -714 | -1,880 | -3,133 | -8,761 | -3,484 | -5,961 |
| Cash from financing | -3,375 | -5,898 | -2,335 | -1,823 | -3,386 | -1,603 | -2,347 | 3,470 | -16,199 | -13,784 | 35,319 |